title: [Bevacizumab treatment for acquired vitelliform detachment in patient with cuticular drusen].
abstract: METHODS
  We report a case of a 30-year-old male with acquired vitelliform detachment (AVD) secondary to cuticular drusen and suffering from metamorphopsia in his right eye. Intravitreal bevacizumab (Avastin) was administered, achieving successful results.
  
  
  CONCLUSIONS
  An independent disease, of unknown genetic phenotype, caused by a generalized dysfunction of the retinal pigment epithelium (RPE). About 50% of patients develop AVD, and a correct diagnosis can be made with the help of new complementary tests. With no effective treatment currently available, and because of the incidence of developing choroidal neovascularization (NVC), treatment with anti-VEGF could help stabilize or improve the disease functionally and/or anatomically.
authors.affiliation: Servicio de Oftalmología, Hospital Universitario Virgen de la Victoria, Málaga, España. Electronic address: dramorillo@hotmail.com.
authors.forename: M J
authors.initials: MJ
authors.lastname: Morillo
authors.affiliation: Servicio de Oftalmología, Hospital Universitario Virgen de la Victoria, Málaga, España.
authors.forename: A B
authors.initials: AB
authors.lastname: González-Escobar
authors.affiliation: Servicio de Oftalmología, Hospital Universitario Virgen de la Victoria, Málaga, España.
authors.forename: I
authors.initials: I
authors.lastname: Baquero
authors.affiliation: Servicio de Oftalmología, Hospital Universitario Virgen de la Victoria, Málaga, España.
authors.forename: J M
authors.initials: JM
authors.lastname: García-Campos
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000008:administration & dosage / Q000627:therapeutic use*; D016570:Bruch Membrane / Q000473:pathology*; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D004630:Emergencies; D015785:Eye Diseases, Hereditary / Q000150:complications*; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D012163:Retinal Detachment / Q000188:drug therapy* / Q000209:etiology; D015593:Retinal Drusen / Q000150:complications*; D041623:Tomography, Optical Coherence; D014786:Vision Disorders / Q000209:etiology
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab
keywords: Acquired vitelliform detachment; Autofluorescence; Autofluorescencia; Bevacizumab; Cuticular drusen; Desprendimiento viteliforme adquirido; Drusas cuticulares; Optical coherence tomography; Tomografía óptica de coherencia